Eccoci con un'altra puntata del Podcast del Corso di Biotecnologie Immunologiche!
In questa puntata verranno trattati sia gli aspetti legati alla malattia della febbre tifoide, che quelli riguardanti le terapie preventive che oggi vengono utilizzate in Europa e nel mondo.

Ringraziamo gli ospiti che ci hanno accompagnato in questa chiaccherata: il Dott. Miles Minio dell'Università Politecnica delle Marche e il Dott. Gianmarco Carnio dell'Univerità degli Studi di Padova.

I nostri contatti:
filippo.brun@studenti.unipd.it
alice.fincato@studenti.unipd.it
martina.quagluata@studenti.unipd.it

Se ne volete sapere di più:

Kim S, Frye JG, Hu J, Fedorka-Cray PJ, Gautom R, Boyle DS. Multiplex PCR-based method for identification of common clinical serotypes of Salmonella enterica subsp. enterica. J Clin Microbiol. 2006 Oct;44(10):3608-15. doi: 10.1128/JCM.00701-06. Epub 2006 Aug 30. PMID: 16943358; PMCID: PMC1594780.

Al-Khafaji, N S, Al-Bayati, A M, Al-Dahmoshi, H O. Virulence Factors of Salmonella Typhi. London: IntechOpen; 2021 [cited 2023 Jan 02]. Available from: https://www.intechopen.com/chapters/74829 doi: 10.5772/intechopen.95587

Gonzalez-Escobedo G, Marshall JM, Gunn JS. Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state. Nat Rev Microbiol. 2011 Jan;9(1):9-14. doi: 10.1038/nrmicro2490. Epub 2010 Nov 29. PMID: 21113180; PMCID: PMC3255095.

Masuet-Aumatell C, Atouguia J. Typhoid fever infection - Antibiotic resistance and vaccination strategies: A narrative review. Travel Med Infect Dis. 2021 Mar-Apr;40:101946. doi: 10.1016/j.tmaid.2020.101946. Epub 2020 Dec 8. PMID: 33301931.

Mukhopadhyay B, Sur D, Gupta SS, Ganguly NK. Typhoid fever: Control & challenges in India. Indian J Med Res. 2019;150(5):437-447. doi:10.4103/ijmr.IJMR_411_18

Marchello CS, Carr SD, Crump JA. A Systematic Review on Antimicrobial Resistance among Salmonella Typhi Worldwide. Am J Trop Med Hyg. 2020 Dec;103(6):2518-2527. doi: 10.4269/ajtmh.20-0258. Epub 2020 Sep 24. PMID: 32996447; PMCID: PMC7695120.

Date KA, Bentsi-Enchill A, Marks F, Fox K. Typhoid fever vaccination strategies. Vaccine. 2015 Jun 19;33 Suppl 3:C55-61. doi: 10.1016/j.vaccine.2015.04.028. Epub 2015 Apr 19. PMID: 25902360.

O'Reilly PJ, Pant D, Shakya M, Basnyat B, Pollard AJ. Progress in the overall understanding of typhoid fever: implications for vaccine development. Expert Rev Vaccines. 2020 Apr;19(4):367-382. doi: 10.1080/14760584.2020.1750375. Epub 2020 Apr 17. PMID: 32238006

Garmory HS, Brown KA, Titball RW. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev. 2002 Nov;26(4):339-53. doi: 10.1111/j.1574-6976.2002.tb00619.x. PMID: 12413664

Hone DM, Attridge SR, Forrest B, Morona R, Daniels D, LaBrooy JT, Bartholomeusz RC, Shearman DJ, Hackett J. A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect Immun. 1988 May;56(5):1326-33. doi: 10.1128/iai.56.5.1326-1333.1988. PMID: 3356467; PMCID: PMC259821.

Hone D, Morona R, Attridge S, Hackett J. Construction of defined galE mutants of Salmonella for use as vaccines. J Infect Dis. 1987 Jul;156(1):167-74. doi: 10.1093/infdis/156.1.167. PMID: 3036954.

Levine MM, Ferreccio C, Cryz S, Ortiz E. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet. 1990 Oct 13;336(8720):891-4. doi: 10.1016/0140-6736(90)92266-k. PMID: 1976928.

Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine. 1999 Oct 1;17 Suppl 2:S22-7. doi: 10.1016/s0264-410x(99)00231-5. PMID: 10506405.